Premium
Nivolumab PD‐1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus
Author(s) -
Wernham A. G. H.,
Shah F.,
Velangi S.
Publication year - 2019
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.13825
Subject(s) - lichen sclerosus , medicine , dermatology , nivolumab , anus neoplasms , immunotherapy , surgery , anal canal , immune system , immunology , rectum